Evidence map›Paper›PMID 28035030›Full record

ArticleBioinformatics (Oxford, England)2017

CAME: identification of chromatin accessibility from nucleosome occupancy and methylome sequencing.

Yongjun Piao, Seong Keon Lee, Eun-Joon Lee, Keith D Robertson, Huidong Shi, Keun Ho Ryu, Jeong-Hyeon Choi

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Comprehensive Evaluation of Differential Methylation Analysis Methods for Bisulfite Sequencing Data.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yongjun PiaoCancer Center, Georgia Regents University, Augusta, GA, USA.
Seong Keon LeeDepartment of Statistics, Sungshin Women's University, Seoul, Republic of Korea.
Eun-Joon LeeCancer Center, Georgia Regents University, Augusta, GA, USA.
Keith D RobertsonDepartment of Molecular Pharmacology and Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Huidong ShiCancer Center, Georgia Regents University, Augusta, GA, USA.
Keun Ho RyuCollege of Electrical and Computer Engineering, Chungbuk National University, Cheongju, Republic of Korea.
Jeong-Hyeon ChoiCancer Center, Georgia Regents University, Augusta, GA, USA.

Funding

RNA epigenetic regulation of cancer metabolismR01CA190429 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HAN-FEI DING · 2014 to 2026
$3.7M
De novo methyltransferase function in chromatin &cancerR01CA114229 · NCI · UNIVERSITY OF FLORIDA · PI ROBERTSON, KEITH D · 2005 to 2017
$3.3M
Developmental pathways, environmental agents, and epigenetics in liver diseaseR01AA019976 · NIAAA · MAYO CLINIC ROCHESTER · PI LIU, CHEN, ROBERTSON, KEITH D · 2011 to 2015
$3.0M
Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemiaR21CA185833 · NCI · AUGUSTA UNIVERSITY · PI SHI, HUIDONG · 2014 to 2015
$362k
NCI NIH HHS R01 CA114229NCI NIH HHS R01 CA190429NCI NIH HHS R21 CA185833NIAAA NIH HHS R01 AA019976
6 · The paper itself

Abstract

Motivation: Chromatin accessibility plays a key role in epigenetic regulation of gene activation and silencing. Open chromatin regions allow regulatory elements such as transcription factors and polymerases to bind for gene expression while closed chromatin regions prevent the activity of transcriptional machinery. Recently, Methyltransferase Accessibility Protocol for individual templates-Bisulfite Genome Sequencing (MAPit-BGS) and nucleosome occupancy and methylome sequencing (NOMe-seq) have been developed for simultaneously profiling chromatin accessibility and DNA methylation on single molecules. Therefore, there is a great demand in developing computational methods to identify chromatin accessibility from MAPit-BGS and NOMe-seq. Results: In this article, we present CAME (Chromatin Accessibility and Methylation), a seed-extension based approach that identifies chromatin accessibility from NOMe-seq. The efficiency and effectiveness of CAME were demonstrated through comparisons with other existing techniques on both simulated and real data, and the results show that our method not only can precisely identify chromatin accessibility but also outperforms other methods. Availability and Implementation: CAME is implemented in java and the program is freely available online at http://sourceforge.net/projects/came/. Contacts: jechoi@gru.edu or khryu@dblab.chungbuk.ac.kr. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

SoftwareAlgorithmsBase SequenceColonic NeoplasmsComputer SimulationCpG IslandsDatabases, GeneticDNA MethylationEpigenesis, GeneticHCT116 CellsHumansNucleic Acid ConformationNucleosomesReference StandardsROC CurveSequence Analysis, DNANucleosomes

Identifiers

PMID28035030
PMCPMC6041946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.